Hepatic Steatosis Associated With Exposure to Elvitegravir and Raltegravir
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Dokumenter
- Hepatic Steatosis Associated With Exposure to Elvitegravir and Raltegravir
Forlagets udgivne version, 293 KB, PDF-dokument
Moderate-to-severe hepatic steatosis in people living with human immunodeficiency virus (HIV) without viral hepatitis or excessive alcohol intake was associated with cumulative exposure to stavudine, elvitegravir, and raltegravir. Prospective trials are required to establish a causal association. Clinical Trials Registration. NCT02382822.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
Vol/bind | 73 |
Udgave nummer | 3 |
Sider (fra-til) | e811-e814 |
ISSN | 1058-4838 |
DOI | |
Status | Udgivet - 2021 |
Bibliografisk note
Publisher Copyright:
© Crown copyright 2021.
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
Ingen data tilgængelig
ID: 279274657